je.st
news
Tag: additional
BART to purchase additional 365 cars for Fleet of the Future
2013-11-25 01:00:00| Railway Technology
The board of San Francisco Bay Area Rapid Transit (BART) has given clearance to purchase an additional 365 cars, intended to completely replace the agency's existing fleet of 669 rail cars with a total of 775 new units.
Tags: the
additional
future
purchase
ADDITIONAL VITAMINS NEEDED BEYOND BREEDING SECTOR
2013-11-20 23:47:26| Cattle Today
Over the last few issues we have taken an in-depth look at vitamin nutrition in beef cattle – primarily those cattle in the cow-calf sector of the production pipeline. As we look past the breeding and calf production part of the industry and consider the next stages, stocker, preconditioning/background and feedlot stages we start seeing a need for more than just the basics – A, D and E.
Tags: additional
needed
sector
breeding
RTI International Receives Additional Funding From Gates Foundation to Advance Toilet Reinvention
2013-11-19 17:55:48| Industrial Machines - Topix.net
RTI received additional funding from the Bill & Melinda Gates Foundation Reinvent the Toilet Challenge to further develop an off-grid toilet-targeted at developing nations-that converts human waste into burnable fuel, stored energy and disinfected, non-potable water through a new biomass conversion unit.
Tags: international
additional
foundation
advance
France proposes two additional light rail lines in Tel Aviv
2013-11-19 01:00:00| Railway Technology
The French Government has proposed the construction of two additional light rail lines in Tel Aviv, Israel, for a total estimated budget of ILS30bn ($8.5bn).
Tags: tel
france
additional
light
Additional Interim Data for Mercks Investigational Anti-PD-1 Immunotherapy, MK-3475, Shows Estimated Overall Survival Rate of 81 Percent at One Year in Patients with Advanced Melanoma
2013-11-18 18:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional data for MK-3475, an investigational anti-PD-1 immunotherapy, in patients with advanced melanoma that showed an estimated overall survival rate of 81 percent at one year across all MK-3475 monotherapy doses evaluated. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] next »